SIBIA Neurosciences (SIBI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SIBIA Neurosciences (SIBI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (394)	6/24/1999 1:33:00 PM
From: scaram(o)uche	Read Replies (1) of 579

Believe me, I don't feel that sellers are sinners. - g - OTOH, I feel that the company is worth $20/share if both 1553 and 1508 were to fall flat on their faces. I never expected to see research premiums and patents discounted to this degree, and I never expected to see us arriving at "1553 crunch time" at this ridiculous valuation. If the 1553 results don't look good, I have a strategy in place....... I may have a one-stock portfolio going forward. >> "Unfortunately, the bad news is that all your rights have been returned to Satan." << Hehehe..... "all your options have been blown to hell". Figures that the attorneys would show up fast. - g - It seems unlikely, IMO, that companies like Wyeth Ayerst, Bristol-Myers Squibb, SmithKline Beecham, Eli Lilly (through Aurora), Novartis, etc. would have each used the assay only for the development of a single molecule.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next